A point mutation uncouples human interleukin-1 beta biological activity and receptor binding.
Open Access
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 265 (11) , 5922-5925
- https://doi.org/10.1016/s0021-9258(19)39265-8
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitorNature, 1990
- Crystal structure of recombinant human interleukin-1β at 2·0 Å resolutionJournal of Molecular Biology, 1989
- cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin SuperfamilyScience, 1988
- Muteins of human interleukin‐1 that show enhanced bioactivitiesFEBS Letters, 1987
- Point mutations of human interleukin‐1 with decreased receptor binding affinityFEBS Letters, 1986
- The cell surface receptors for interleukin-1α and interleukin-1β are identicalNature, 1986
- There is more than one interleukin 1Immunology Today, 1986
- Interleukin-1Clinical Infectious Diseases, 1984
- Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells.The Journal of Experimental Medicine, 1983